Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer
The current work demonstrates improved PROs from a phase II functional avoidance trial in certain subscales (FACT-TOI and EQ-VAS) compared with PROs from seminal studies (RTOG 0617 and PACIFIC). The presented data support investigation of 4DCT functional avoidance in a phase III setting.
Authors
- Benjamin Movsas (ORCID: https://orcid.org/0000-0003-2703-9776)
- Spencer Poiset (ORCID: https://orcid.org/0000-0002-2725-4807)
- Cullen Boyle (ORCID: https://orcid.org/0009-0005-9941-3570)
- Edward Castillo (ORCID: https://orcid.org/0000-0003-0523-487X)
- Bernard L. Jones (ORCID: https://orcid.org/0000-0001-7169-559X)
- Adam P. Dicker (ORCID: https://orcid.org/0000-0003-0733-3337)
- Joseph Lombardo (ORCID: https://orcid.org/0000-0001-9386-4438)
- Brian D. Kavanagh (ORCID: https://orcid.org/0000-0001-5579-1725)
- Yevgeniy Vinogradskiy (ORCID: https://orcid.org/0000-0002-5359-6245)
- Nicole L. Simone (ORCID: https://orcid.org/0000-0002-7662-7470)
- Moyed Miften
- Richard Castillo (ORCID: https://orcid.org/0000-0001-6541-6021)
- Lydia Wilson (ORCID: https://orcid.org/0000-0002-9959-9310)
- Chad G. Rusthoven (ORCID: https://orcid.org/0000-0002-6978-2077)
- Inga S. Grills
Institutions
- Thomas Jefferson University (US)
- Emory University (US)
- Beaumont Health (US)
- University of Colorado Cancer Center (US)
- The University of Texas at Austin (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- JCO Clinical Cancer Informatics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1200/cci-24-00202
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute